Gourt > Health > Pharmacy > Drugs and Medications > B > Bosentan
Bosentan is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). It's trade name is Tracleer®, which is an oral medication licensed in the U.S., European Union and other countries for the management of PAH. The license holder is Actelion Pharmaceuticals.
More on [ Bosentan ]
Bosentan Therapy for Pulmonary Arterial Hypertension - Actelion's slide show presentation to the FDA.
FDA Approves First Oral Medication for Pulmonary Arterial Hypertension - Describes the trial results and subsequent approval of Tracleer.
Meta Description: [ FDA Approves First Oral Medication for Pulmonary Arterial Hypertension ]
MedlinePlus: Bosentan - Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations
Meta Description: [ Bosentan ]
Tracleer - Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.
| Importance of Monitoring Liver Function with Tracleer | |
